Updating results

829 results

Sort: Relevance | Date

SeQuent Please balloon catheter for in-stent coronary restenosis (MTG1)

Evidence-based recommendations on SeQuent Please balloon catheter for in-stent coronary restenosis

Medical technologies guidance Published December 2010

PleurX peritoneal catheter drainage system for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites (MTG9)

Evidence-based recommendations on PleurX peritoneal catheter drainage system for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites

Medical technologies guidance Published March 2012 Last updated February 2018

MiraQ for assessing graft flow during coronary artery bypass graft surgery (MTG8)

Evidence-based recommendations on MiraQ for assessing graft flow during coronary artery bypass graft surgery

Medical technologies guidance Published November 2011 Last updated February 2018

Ambulight PDT for the treatment of non-melanoma skin cancer (MTG6)

Evidence-based recommendations on Ambulight PDT for the treatment of non-melanoma skin cancer

Medical technologies guidance Published July 2011

The MIST Therapy system for the promotion of wound healing (MTG5)

Evidence-based recommendations on the MIST Therapy system for the promotion of wound healing

Medical technologies guidance Published July 2011

Episcissors-60 for mediolateral episiotomy (MTG47)

Evidence-based recommendations on Episcissors-60 for mediolateral episiotomy

Medical technologies guidance Published February 2020

UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia (MTG26)

Evidence-based recommendations on UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia (BHP)

Medical technologies guidance Published September 2015

Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C (MTG27)

Evidence-based recommendations on Virtual Touch Quantification for diagnosing and monitoring liver fibrosis in chronic Hepatitis B and C

Medical technologies guidance Published September 2015 Last updated January 2020

UrgoStart for treating diabetic foot ulcers and leg ulcers (MTG42)

Evidence-based recommendations on UrgoStart for treating diabetic foot ulcers and leg ulcers

Medical technologies guidance Published January 2019

Mepilex Border Heel and Sacrum dressings for preventing pressure ulcers (MTG40)

Evidence-based recommendations on Mepilex Border Heel and Sacrum dressings for preventing pressure ulcers

Medical technologies guidance Published January 2019

Peristeen transanal irrigation system for managing bowel dysfunction (MTG36)

Evidence-based recommendations on the Peristeen transanal irrigation system for people with bowel dysfunction

Medical technologies guidance Published February 2018

Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic pain (MTG41)

Evidence-based recommendations on the Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic pain

Medical technologies guidance Published January 2019

iFuse for treating chronic sacroiliac joint pain (MTG39)

Evidence-based recommendations on iFuse titanium implant joint fusion system for treating chronic sacroiliac (SI) joint pain (lower back pain)

Medical technologies guidance Published October 2018

Neuropad for detecting preclinical diabetic peripheral neuropathy (MTG38)

Evidence-based recommendations on Neuropad for detecting preclinical diabetic peripheral neuropathy (nerve damage) by detecting inadequate sweat production

Medical technologies guidance Published September 2018

Thopaz+ portable digital system for managing chest drains (MTG37)

Evidence-based recommendations on Thopaz+ for people who need chest drainage after a pulmonary resection or because of a collapsed lung

Medical technologies guidance Published March 2018

Memokath-051 stent for ureteric obstruction (MTG35)

Evidence-based recommendations on Memokath-051 stent for treating ureteric obstruction

Medical technologies guidance Published February 2018

SecurAcath for securing percutaneous catheters (MTG34)

Evidence-based recommendations on SecurAcath for securing percutaneous catheters (central venous catheters/CVCs)

Medical technologies guidance Published June 2017

ENDURALIFE powered CRT-D devices for treating heart failure (MTG33)

Evidence-based recommendations on ENDURALIFE-powered cardiac resynchronisation therapy-defibrillator (CRT-D) devices for treating heart failure

Medical technologies guidance Published March 2017

HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography (MTG32)

Evidence-based recommendations on HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography

Medical technologies guidance Published February 2017

HumiGard for preventing inadvertent perioperative hypothermia (MTG31)

Evidence-based recommendations on HumiGard for preventing inadvertent perioperative hypothermia in patients having abdominal surgery

Medical technologies guidance Published February 2017

XprESS multi sinus dilation system for treating chronic sinusitis (MTG30)

Evidence-based recommendations on the XprESS multi-sinus dilation system for treating chronic sinusitis after medical treatment has failed

Medical technologies guidance Published December 2016

CardioQ-ODM oesophageal doppler monitor (MTG3)

Evidence-based recommendations on the CardioQ-ODM oesophageal doppler monitor for people having major or high-risk surgery

Medical technologies guidance Published March 2011

GreenLight XPS for treating benign prostatic hyperplasia (MTG29)

Evidence-based recommendations on GreenLight XPS for treating benign prostatic hyperplasia (BPH)

Medical technologies guidance Published June 2016

PICO negative pressure wound dressings for closed surgical incisions (MTG43)

Evidence-based recommendations on PICO negative pressure wound dressings for closed surgical incisions

Medical technologies guidance Published May 2019 Last updated August 2019

The 3M Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites (MTG25)

Evidence-based recommendations on the 3M Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites

Medical technologies guidance Published July 2015 Last updated September 2019

E‑vita open plus for treating complex aneurysms and dissections of the thoracic aorta (MTG16)

Evidence-based recommendations on the E-vita open plus for treating complex aneurysms and dissections of the thoracic aorta

Medical technologies guidance Published December 2013 Last updated October 2018

The ReCell Spray‑On Skin system for treating skin loss, scarring and depigmentation after burn injury (MTG21)

Evidence-based recommendations on the ReCell Spray-On Skin system for treating skin loss, scarring and depigmentation after burn injury

Medical technologies guidance Published November 2014

The V.A.C. Veraflo Therapy system for infected wounds

In development [GID-MT543] Expected publication date: 06 October 2020

Medical technologies guidance In development

SpaceOAR hydrogel spacer for reducing rectal toxicity during radiotherapy for prostate cancer (Suspended – referred to technology appraisals)

In development [GID-MT526] Expected publication date: TBC

Medical technologies guidance In development

SEM Scanner 200 for pressure ulcer prevention

In development [GID-MT533] Expected publication date: 06 July 2020

Medical technologies guidance In development

DHT pilot: Lifelight First for monitoring vital signs

In development [GID-MT532] Expected publication date: TBC

Medical technologies guidance In development

DHT pilot: MyCOPD for self-management of chronic obstructive pulmonary disease (COPD)

In development [GID-MT531] Expected publication date: TBC

Medical technologies guidance In development

DHT pilot: Zio XT Service for detecting cardiac arrhythmias

In development [GID-MT534] Expected publication date: TBC

Medical technologies guidance In development

Danis Stent for acute oesophageal variceal bleeds

In development [GID-MT537] Expected publication date: 21 December 2020

Medical technologies guidance In development

Leukomed Sorbact

In development [GID-MT541] Expected publication date: 22 December 2020

Medical technologies guidance In development

Endo-Sponge for treating colorectal anastomotic leakage

In development [GID-MT539] Expected publication date: 01 September 2020

Medical technologies guidance In development

PneuX for preventing ventilator-associated pneumonia in intensive care

In development [GID-MT528] Expected publication date: 27 March 2020

Medical technologies guidance In development

Axonics sacral neuromodulation system for bladder control in people with symptoms of overactive bladder

In development [GID-MT530] Expected publication date: 01 June 2020

Medical technologies guidance In development

Peezy Midstream for urine collection (SUSPENDED)

In development [GID-MT538] Expected publication date: TBC

Medical technologies guidance In development

DHT pilot: DECODE decision support system for the identification of dementia

In development [GID-MT536] Expected publication date: TBC

Medical technologies guidance In development

Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia

In development [GID-MT529] Expected publication date: 06 April 2020

Medical technologies guidance In development

The MAGEC system for spinal lengthening in children with scoliosis

In development [GID-MT544] Expected publication date: 15 September 2020

Medical technologies guidance In development

Improving outcomes in haemato-oncology cancer (CSG3)

This guidance has been updated and replaced by NICE guideline NG47.

Cancer service guideline Published October 2003

Improving outcomes in colorectal cancer (CSG5)

This guidance has been updated and replaced by NICE guideline NG151

Cancer service guideline Published June 2004

Drisapersen for the first-line treatment of Duchenne's muscular dystrophy [ID911]

In development [GID-HST10004] Expected publication date: TBC

Highly specialised technologies guidance In development

Eteplirsen for treating Duchenne muscular dystrophy [ID1003]

In development [GID-HST10007] Expected publication date: TBC

Highly specialised technologies guidance In development

Microwave ablation of hepatocellular carcinoma (IPG214)

Evidence-based recommendations on microwave ablation of for treating hepatocellular carcinoma (primary liver cancer)

Interventional procedures guidance Published March 2007

Laparoscopic nephrolithotomy and pyelolithotomy (IPG212)

Evidence-based recommendations on laparoscopic nephrolithotomy and pyelolithotomy for treating renal (kidney) stones

Interventional procedures guidance Published March 2007

Radiofrequency-assisted liver resection (IPG211)

Evidence-based recommendations on radiofrequency-assisted liver resection for treating primary or secondary liver cancer

Interventional procedures guidance Published February 2007

Injectable bulking agents for faecal incontinence (IPG210)

Evidence-based recommendations on injectable bulking agents for treating faecal incontinence (bowel or anal incontinence)

Interventional procedures guidance Published February 2007